关于肌性 dystonia 综合征的方法:欧洲参考网络调查调查
María I Vanegas1, Anna Marcé-Grau2, Ana Cazurro-Gutiérrez2,3
1Children's Neurosciences, Evelina London Children's Hospital, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
Movement disorders clinical practice
|March 15, 2025
概括
肌肌-静脉缩综合征 (MDS) 是一种遗传性疾病,通常在童年时被诊断出来. 建议采用多学科的方法来改善运动和神经精神症状的诊断和治疗.
科学领域:
- 神经学 神经学
- 遗传学 遗传学 是一个
- 罕见疾病 罕见疾病
背景情况:
- 肌肌-静脉缩综合征 (MDS) 是一种发病于儿童时期的遗传运动障碍,经常与SGCE基因缺陷有关.
- 了解当前的诊断和治疗策略对于管理这种罕见的疾病至关重要.
研究的目的:
- 在欧洲专家中评估MDS的诊断和治疗策略.
- 评估患者和家庭对MDS诊断和管理的经验.
主要方法:
- 在欧洲罕见神经疾病参考网络 (ERN-RND) 中的神经病学家和与SGCE相关的MDS.患者/家属分发了两个问卷.
- 来自14个国家的29名神经科医生和来自12个国家的84名患者/护理人员收集了数据.
主要成果:
- 所有分析的患者都患有SGCE相关的MDS,平均年龄为30.8岁;69%在童年时被诊断出来.
- 肌和 dystonia 在80%的患者中显著影响了日常活动. 毒素和DBS显示出有效性,但没有得到最佳应用.
- 在管理学术困难和高失业率方面发现了缺陷. 精神症状很普遍,但通常缺乏正式的评估.
结论:
- 欧洲运动障碍专家认可SGCE-MDS.
- 解决运动障碍和神经精神病相关疾病的多学科方法对于改善患者的治疗结果至关重要.
相关概念视频
Classification of Skeletal Muscle Relaxants
2.3K
Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
2.3K
Peripherally and Centrally Acting Muscle Relaxants: A Comparison
3.1K
Skeletal muscle relaxants can target the central nervous system [CNS] to reduce muscle tension or act directly at the neuromuscular junction to induce temporary paralysis. These two classes of muscle relaxants are called centrally acting muscle relaxants and peripherally acting muscle relaxants. They differ in their action, mechanism, administration route, and clinical uses.
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
3.1K
Disorders of the Skeletal Muscle
845
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
845
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
642
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
642
Myasthenia Gravis: Overview and Treatment
1.1K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.1K
Skeletal Muscle Relaxants: Therapeutic Uses
449
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
449


